EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSCHAG00000027268
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSCHAG00000010070
Gene Symbol: TLR8
1 Cross references
184 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSCHAG00000020310
Gene Symbol: LOC105901157
3 Cross references
713 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 A

Ensembl ID : ENSCHAG00000025063
Gene Symbol: TGFBR1A
1 Cross references
161 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1a

Ensembl ID : ENSCHAG00000026902
Gene Symbol: TRPA1A
1 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSCHAG00000021829
Gene Symbol: TRPA1B
1 Cross references
201 Possible Orthologues:

Transthyretin

Ensembl ID : ENSCHAG00000005935
Gene Symbol: TTR
3 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCHAG00000023761
Gene Symbol: TPH1
3 Cross references
150 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCHAG00000021362
Gene Symbol: TPH1
1 Cross references
197 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSCHAG00000021409
Gene Symbol: TUBA4A
1 Cross references
109 Possible Orthologues:

Tubulin Alpha Chain, Testis-Specific

Ensembl ID : ENSCHAG00000014382
Gene Symbol: LOC105889199
3 Cross references
217 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSCHAG00000024583
Gene Symbol: LOC105911822
3 Cross references
154 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).